Chowdhury Chiranjit, Sinha Sharmistha, Chun Sunny, Yeates Todd O, Bobik Thomas A
Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, Iowa, USA.
Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA.
Microbiol Mol Biol Rev. 2014 Sep;78(3):438-68. doi: 10.1128/MMBR.00009-14.
Bacterial microcompartments (MCPs) are sophisticated protein-based organelles used to optimize metabolic pathways. They consist of metabolic enzymes encapsulated within a protein shell, which creates an ideal environment for catalysis and facilitates the channeling of toxic/volatile intermediates to downstream enzymes. The metabolic processes that require MCPs are diverse and widely distributed and play important roles in global carbon fixation and bacterial pathogenesis. The protein shells of MCPs are thought to selectively control the movement of enzyme cofactors, substrates, and products (including toxic or volatile intermediates) between the MCP interior and the cytoplasm of the cell using both passive electrostatic/steric and dynamic gated mechanisms. Evidence suggests that specialized shell proteins conduct electrons between the cytoplasm and the lumen of the MCP and/or help rebuild damaged iron-sulfur centers in the encapsulated enzymes. The MCP shell is elaborated through a family of small proteins whose structural core is known as a bacterial microcompartment (BMC) domain. BMC domain proteins oligomerize into flat, hexagonally shaped tiles, which assemble into extended protein sheets that form the facets of the shell. Shape complementarity along the edges allows different types of BMC domain proteins to form mixed sheets, while sequence variation provides functional diversification. Recent studies have also revealed targeting sequences that mediate protein encapsulation within MCPs, scaffolding proteins that organize lumen enzymes and the use of private cofactor pools (NAD/H and coenzyme A [HS-CoA]) to facilitate cofactor homeostasis. Although much remains to be learned, our growing understanding of MCPs is providing a basis for bioengineering of protein-based containers for the production of chemicals/pharmaceuticals and for use as molecular delivery vehicles.
细菌微区室(MCPs)是用于优化代谢途径的复杂蛋白质基细胞器。它们由包裹在蛋白质外壳内的代谢酶组成,这为催化创造了理想环境,并促进有毒/挥发性中间体向下游酶的传递。需要MCPs的代谢过程多种多样且分布广泛,在全球碳固定和细菌致病过程中发挥着重要作用。MCPs的蛋白质外壳被认为通过被动静电/空间位阻和动态门控机制,选择性地控制酶辅因子、底物和产物(包括有毒或挥发性中间体)在MCP内部与细胞胞质之间的移动。有证据表明,特殊的外壳蛋白在胞质与MCP内腔之间传导电子,和/或帮助重建被包裹酶中受损的铁硫中心。MCP外壳由一类小蛋白质构建而成,其结构核心被称为细菌微区室(BMC)结构域。BMC结构域蛋白寡聚形成扁平的六边形薄片,这些薄片组装成形成外壳小面的延伸蛋白质片层。沿边缘的形状互补性使不同类型的BMC结构域蛋白能够形成混合片层,而序列变异则提供功能多样性。最近的研究还揭示了介导蛋白质包裹在MCP内的靶向序列、组织内腔酶的支架蛋白,以及利用专用辅因子库(NAD/H和辅酶A[HS-CoA])促进辅因子稳态。尽管仍有许多有待了解的地方,但我们对MCPs不断增加的认识为基于蛋白质的用于化学品/药物生产的容器的生物工程以及用作分子递送载体提供了基础。